Preliminary longitudinal assessment of quality of life in patients with major depression

Psychopharmacology Bulletin

Volumn 33, Issue 1, 1997, Pages 23-29

  Pyne, Jeffrey M ^a,b   Patterson, Thomas L ^a,b   Kaplan, Robert M ^c   Ho, Sandy ^b   Gillin, J Christian ^a,b   Golshan, Shahrokh ^b   Grant, Igor ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Beck Depression Inventory; Hamilton Rating Scale for Depression; major depression; quality of life; quality of well being

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; FEMALE; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE;

DEPRESSIVE DISORDER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE;

EID: 0030940417     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: The Association, 1994.
2. Beck, AT; Ward, CH; Mendelsohn, M; Mock, J; and Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatry 4:561-571, 1961.
3. Bergner, M; Bobbitt, RA; Kressel, S; Pollard, WE; Gilson, BS; and Morris, JR. The Sickness Impact Profile: Conceptual foundation and methodology for the development of a health status measure. Intl. J. Health Serv. 6(3):393-415, 1976.
4. Bombardier, C; Ware, J; Russell, IJ; Larson, M; Chalmers, A; and Read, JL. Auranofin therapy and quality of life for patients with rheumatoid arthritis: Results of a multicenter trial. Am. J. Med. 81:565-578, 1986.
5. Coons, SJ, and Kaplan, RM. Cost-utility analysis. In: Bootman, JL; Townsend, RJ; and McGhan, WF, eds. Principles of Pharmacoeconomics, Second Edition. Harvey Whitney Books Company, 1996. pp. 102-126.
6. Eakin, EG; Sassi-Dambron, D; Kaplan, RM; and Ries, AL. Clinical trial of rehabilitation in chronic obstructive pulmonary disease: Compliance as a mediator of change in exercise tolerance. J. Cardiopulm. Rehabil. 12:105-110, 1992.
7. The EuroQol Group. EuroQol: A new facility for the measurement of health-related quality of life. Health Policy 16:199-208, 1990.
8. Fawcett, J. Antidepressants: Partial response in chronic depression. Br. J. Psychiatry 165(Suppl. 26):37-41, 1994.
9. Feeny, D; Furlong, W; Boyle, M; and Torrance, GW. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics 7(6):490-502, 1995.
10. Ganiats, TG; Palinkas, LA; and Kaplan, RM. Comparison of quality of well-being scale and functional status index in patients with atrial fibrillation. Med. Care 30(10):958-964, 1992.
11. Goldman, HH; Skodol, AE; and Lave, TR. Revising Axis V for DSM-IV: A review of measures of social functioning. Am. J. Psychiatry 149(9):1148-1156, 1992.
12. Grant, I; Patterson, TL; and Yager, J. Social supports in relation to physical health and symptoms of depression in the elderly. Am. J. Psychiatry 145(10):1254-1258, 1988.
13. Hamilton, MA. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:278-296, 1967.
14. Kaplan, RM. Quality of life assessment for cost/utility studies in cancer. Cancer Treat. Rev. 19(Suppl. A):85-96, 1993a.
15. Kaplan, RM. Hippocratic Predicament: Affordability, Access, and Accountability in Health Care. San Diego: Academic Press, 1993b.
16. Kaplan, RM, and Anderson, JP. The general health policy model: An integrated approach. In: Spilker, B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Second Edition. Philadelphia: Lippincott-Raven Publishers, 1996. pp. 309-322.
17. Kaplan, RM; Anderson, JP; Patterson, TL; McCutchan, JA; Weinrich, JD; Heaton, RH; Atkinson, JH; Thai, L; Chandler, J; and Grant, I. Validity of the Quality of Well-Being scale for persons with HIV infection. Psychosom. Med. 57:138-147, 1995.
18. Kaplan, RM; Atkins, CJ; and Timms, R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J. Chron. Dis. 37(2):85-95, 1984.
19. Kaplan, RM; Bush, JW; and Berry, CC. Health status: Types of validity and the index of well-being. Health Serv. Res. 11:478-507, 1976.
20. Kaplan, RM; Bush, JW; and Berry, CC. The reliability, stability, and generalizability of a health status index. American Statistical Association Proceedings of the Social Status Section 704-709, 1978.
21. Kaplan, RM; Coons, SJ; and Anderson, JP. Quality of life and policy in arthritis. Arthritis Care Res. 5(3):173-183, 1992.
22. Kaplan, RM; Hartwell, SL; Wilson, DK; and Wallace, JP. Effects of diet and exercise interventions on control and quality of life in non-insulin dependent diabetes mellitus. J. Gen. Intern. Med. 2(4):220-228, 1987.
23. Orenstein, DM, and Kaplan, RM. Measuring the quality of well-being in cystic fibrosis and lung transplantation: The importance of the area under the curve. Chest 100:1016-1018, 1991.
24. Patterson, TL; Kaplan, RM; Grant, I; Semple, SJ; Moscona, S; Koch, WL; Harris, MJ; and Jeste, DV. Quality of well-being in late life psychosis. Psychiatr. Res. 63:169-181, 1996.
25. Pyne, JM; Patterson, TL; Kaplan, RM; Gillin, JC; Koch, WL; and Grant, I. Quality of life assessment for patients with major depression. Psychiatric Services, in press, 1997.
26. Robins, LN; Helzer, JE; Croughan, JL; and Ratcliff, KS. National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics and validity. Arch. Gen. Psychiatry 38:381-389, 1981.
27. Spitzer, RL, and Endicott, J. Schedule for Affective Disorders and Schizophrenia, 3rd ed. New York, Biometrics Research Division, New York State Psychiatric Institute, 1979.
28. Spitzer, RL; Williams, JBW; Gibbon, M; and First, MD. Structured Clinical Interview for DSM-III-R. New York State Psychiatric Institute, Biometrics Research, 1988.
29. Wells, KB; Stewart, A; Hays, RD; Bumam, MA; Rogers, W; Daniels, M; Berry, S; Greenfield, S; and Ware, J. The functioning and well-being of depressed patients: Results of the Medical Outcomes Study. JAMA 262:914-919, 1989.
30. Wu, AW; Matthews, WC; Brysk, LT; Atkinson, JH; Grant, I; Abramson, I; Kennedy, CJ; McCutchan, JA; Spector, SA; and Richman, DD. Quality of life in a placebo-controlled trial of Zidovudine in patients with AIDS and AIDS-related complex. J. Acquir. Immune Defic. Syndr. 3(7):683-690, 1990.